Biolase EBITDA Margin 2010-2023 | BIOL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Biolase (BIOL) over the last 10 years. The current EBITDA margin for Biolase as of December 31, 2023 is .
| Biolase EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$0.05B |
$-0.01B |
-29.17% |
| 2023-09-30 |
$0.05B |
$-0.02B |
-34.69% |
| 2023-06-30 |
$0.05B |
$-0.02B |
-42.00% |
| 2023-03-31 |
$0.05B |
$-0.02B |
-50.00% |
| 2022-12-31 |
$0.05B |
$-0.02B |
-47.92% |
| 2022-09-30 |
$0.05B |
$-0.02B |
-43.48% |
| 2022-06-30 |
$0.04B |
$-0.02B |
-34.09% |
| 2022-03-31 |
$0.04B |
$-0.01B |
-31.71% |
| 2021-12-31 |
$0.04B |
$-0.02B |
-38.46% |
| 2021-09-30 |
$0.04B |
$-0.02B |
-44.44% |
| 2021-06-30 |
$0.03B |
$-0.02B |
-51.52% |
| 2021-03-31 |
$0.03B |
$-0.02B |
-66.67% |
| 2020-12-31 |
$0.02B |
$-0.02B |
-70.83% |
| 2020-09-30 |
$0.03B |
$-0.02B |
-60.00% |
| 2020-06-30 |
$0.03B |
$-0.02B |
-62.96% |
| 2020-03-31 |
$0.03B |
$-0.02B |
-48.48% |
| 2019-12-31 |
$0.04B |
$-0.02B |
-39.47% |
| 2019-09-30 |
$0.04B |
$-0.02B |
-43.90% |
| 2019-06-30 |
$0.04B |
$-0.02B |
-39.53% |
| 2019-03-31 |
$0.05B |
$-0.02B |
-39.13% |
| 2018-12-31 |
$0.05B |
$-0.02B |
-41.30% |
| 2018-09-30 |
$0.05B |
$-0.02B |
-36.96% |
| 2018-06-30 |
$0.05B |
$-0.02B |
-36.96% |
| 2018-03-31 |
$0.05B |
$-0.02B |
-36.17% |
| 2017-12-31 |
$0.05B |
$-0.02B |
-33.33% |
| 2017-09-30 |
$0.05B |
$-0.02B |
-32.65% |
| 2017-06-30 |
$0.05B |
$-0.02B |
-29.41% |
| 2017-03-31 |
$0.05B |
$-0.01B |
-26.92% |
| 2016-12-31 |
$0.05B |
$-0.01B |
-26.92% |
| 2016-09-30 |
$0.05B |
$-0.01B |
-22.64% |
| 2016-06-30 |
$0.05B |
$-0.01B |
-27.45% |
| 2016-03-31 |
$0.05B |
$-0.02B |
-36.73% |
| 2015-12-31 |
$0.05B |
$-0.02B |
-38.78% |
| 2015-09-30 |
$0.05B |
$-0.02B |
-44.68% |
| 2015-06-30 |
$0.05B |
$-0.02B |
-38.78% |
| 2015-03-31 |
$0.05B |
$-0.02B |
-38.30% |
| 2014-12-31 |
$0.05B |
$-0.02B |
-35.42% |
| 2014-09-30 |
$0.05B |
$-0.02B |
-30.00% |
| 2014-06-30 |
$0.05B |
$-0.02B |
-32.65% |
| 2014-03-31 |
$0.05B |
$-0.01B |
-22.64% |
| 2013-12-31 |
$0.06B |
$-0.01B |
-19.64% |
| 2013-09-30 |
$0.06B |
$-0.01B |
-13.33% |
| 2013-06-30 |
$0.06B |
$-0.00B |
-6.45% |
| 2013-03-31 |
$0.06B |
$-0.00B |
-6.67% |
| 2012-12-31 |
$0.06B |
$-0.00B |
-3.51% |
| 2012-09-30 |
$0.05B |
$-0.01B |
-9.80% |
| 2012-06-30 |
$0.05B |
$-0.01B |
-12.00% |
| 2012-03-31 |
$0.05B |
$-0.01B |
-10.00% |
| 2011-12-31 |
$0.05B |
$-0.00B |
-8.16% |
| 2011-09-30 |
$0.05B |
$-0.00B |
-2.17% |
| 2011-06-30 |
$0.04B |
$-0.00B |
-5.13% |
| 2011-03-31 |
$0.03B |
$-0.01B |
-15.15% |
| 2010-12-31 |
$0.03B |
$-0.01B |
-38.46% |
| 2010-09-30 |
$0.03B |
$-0.01B |
-46.15% |
| 2010-06-30 |
$0.03B |
$-0.01B |
-28.13% |
| 2010-03-31 |
$0.04B |
$-0.00B |
-5.00% |
| 2009-12-31 |
$0.04B |
$-0.00B |
-4.65% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
